ProCE Banner Activity

Phase III MF07-01 Trial: Impact of Initial Local Resection on Stage IV Breast Cancer Survival

Slideset Download
Conference Coverage
With 5-year follow-up, local surgery followed by systemic therapy associated with significant improvement in OS vs initial systemic therapy with local therapy for localized progression in patients with MBC at presentation.

Released: June 06, 2016

Expiration: June 05, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals